Effect of Betablocker or Aldosterone Antagonist Therapy on Patients With Liver Cirrhosis

NCT00332904 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Liver Cirrhosis
Portal Hypertension

Interventions

DRUG: propranolol
DRUG: spironolactone

Sponsor

Hvidovre University Hospital